APA (7th ed.) Citation

Vantaggiato, L., Cameli, P., Bergantini, L., d’Alessandro, M., Shaba, E., Carleo, A., . . . Landi, C. (2022). Serum Proteomic Profile of Asthmatic Patients after Six Months of Benralizumab and Mepolizumab Treatment. Biomedicines, 10(4), 761. https://doi.org/10.3390/biomedicines10040761

Chicago Style (17th ed.) Citation

Vantaggiato, Lorenza, et al. "Serum Proteomic Profile of Asthmatic Patients After Six Months of Benralizumab and Mepolizumab Treatment." Biomedicines 10, no. 4 (2022): 761. https://doi.org/10.3390/biomedicines10040761.

MLA (9th ed.) Citation

Vantaggiato, Lorenza, et al. "Serum Proteomic Profile of Asthmatic Patients After Six Months of Benralizumab and Mepolizumab Treatment." Biomedicines, vol. 10, no. 4, 2022, p. 761, https://doi.org/10.3390/biomedicines10040761.